Wednesday, April 06, 2022 12:58:03 PM
and don't forget this hl...
Mr. Night added that the acquisition would happen in a phased manner due to the nature of business and compliance safeguards. The details of the acquired Company will be disclosed in due course of time; however, it is FDA licensed facility to manufacture prescription, OTC, Nutraceutical, Cosmeceuticals, and a variety of other segments.
If this is the same co PR'd in late 2018, it's obvious, at least to me, where they are manufacturing at...
https://www.sohm.com/2018/12/21/sohm-inc-signs-strategic-alliance-with-manufacturing-unit-in-southern-california-and-expands-product-base-and-revenue-sources/#.XB0b5tmqLDA.twitter
Mr. Night added that the acquisition would happen in a phased manner due to the nature of business and compliance safeguards. The details of the acquired Company will be disclosed in due course of time; however, it is FDA licensed facility to manufacture prescription, OTC, Nutraceutical, Cosmeceuticals, and a variety of other segments.
If this is the same co PR'd in late 2018, it's obvious, at least to me, where they are manufacturing at...
https://www.sohm.com/2018/12/21/sohm-inc-signs-strategic-alliance-with-manufacturing-unit-in-southern-california-and-expands-product-base-and-revenue-sources/#.XB0b5tmqLDA.twitter
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
